Last reviewed · How we verify
Eurartesim® in Patients With Imported Uncomplicated Plasmodium Vivax Malaria
The aim of the present study is to investigate the efficacy, safety and tolerability of a therapeutic course of Eurartesim® in travellers who contracted malaria due to infection by P. vivax in endemic countries.
Details
| Lead sponsor | Alfasigma S.p.A. |
|---|---|
| Phase | PHASE2 |
| Status | TERMINATED |
| Enrolment | 27 |
| Start date | Wed Jun 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Sun Apr 30 2017 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Malaria, Vivax
Interventions
- Eurartesim tablets
Countries
France, Italy, Netherlands, Israel, Germany, Switzerland, Spain